CSTL logo

Castle Biosciences, Inc. (CSTL) Net income

annual net income:

$18.25M+$75.71M(+131.75%)
December 31, 2024

Summary

  • As of today (September 1, 2025), CSTL annual net profit is $18.25 million, with the most recent change of +$75.71 million (+131.75%) on December 31, 2024.
  • During the last 3 years, CSTL annual net income has risen by +$49.54 million (+158.31%).
  • CSTL annual net income is now at all-time high.

Performance

CSTL Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSTLincome statement metrics

quarterly net income:

$4.52M+$30.37M(+117.50%)
June 30, 2025

Summary

  • As of today (September 1, 2025), CSTL quarterly net profit is $4.52 million, with the most recent change of +$30.37 million (+117.50%) on June 30, 2025.
  • Over the past year, CSTL quarterly net income has dropped by -$4.40 million (-49.29%).
  • CSTL quarterly net income is now -52.84% below its all-time high of $9.59 million, reached on December 31, 2024.

Performance

CSTL quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSTLincome statement metrics

TTM net income:

-$9.47M-$4.40M(-86.74%)
June 30, 2025

Summary

  • As of today (September 1, 2025), CSTL TTM net profit is -$9.47 million, with the most recent change of -$4.40 million (-86.74%) on June 30, 2025.
  • Over the past year, CSTL TTM net income has dropped by -$6.37 million (-205.45%).
  • CSTL TTM net income is now -151.88% below its all-time high of $18.25 million, reached on December 31, 2024.

Performance

CSTL TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSTLincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CSTL Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+131.8%-49.3%-205.4%
3 y3 years+158.3%+374.4%+78.7%
5 y5 years+245.8%+428.7%-233.4%

CSTL Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+127.2%-52.8%+115.5%-151.9%+89.3%
5 y5-yearat high+127.2%-52.8%+115.5%-151.9%+89.3%
alltimeall timeat high+127.2%-52.8%+115.5%-151.9%+89.3%

CSTL Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.52M(-117.5%)
-$9.47M(+86.7%)
Mar 2025
-
-$25.85M(-369.5%)
-$5.07M(-127.8%)
Dec 2024
$18.25M(-131.7%)
$9.59M(+322.7%)
$18.25M(+200.3%)
Sep 2024
-
$2.27M(-74.6%)
$6.08M(-296.0%)
Jun 2024
-
$8.92M(-452.0%)
-$3.10M(-89.9%)
Mar 2024
-
-$2.53M(-1.8%)
-$30.80M(-46.4%)
Dec 2023
-$57.47M(-14.4%)
-$2.58M(-62.6%)
-$57.47M(-23.9%)
Sep 2023
-
-$6.91M(-63.2%)
-$75.50M(-15.0%)
Jun 2023
-
-$18.78M(-35.7%)
-$88.85M(+23.9%)
Mar 2023
-
-$29.20M(+41.6%)
-$71.72M(+6.8%)
Dec 2022
-$67.14M(+114.6%)
-$20.62M(+1.8%)
-$67.14M(+26.8%)
Sep 2022
-
-$20.25M(+1128.7%)
-$52.95M(+19.0%)
Jun 2022
-
-$1.65M(-93.3%)
-$44.49M(-13.8%)
Mar 2022
-
-$24.62M(+282.9%)
-$51.63M(+65.0%)
Dec 2021
-$31.29M
-$6.43M(-45.5%)
-$31.29M(+5.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$11.79M(+34.1%)
-$29.75M(+31.9%)
Jun 2021
-
-$8.79M(+105.4%)
-$22.55M(+49.0%)
Mar 2021
-
-$4.28M(-12.5%)
-$15.13M(+47.2%)
Dec 2020
-$10.28M(-294.9%)
-$4.89M(+6.5%)
-$10.28M(+207.9%)
Sep 2020
-
-$4.59M(+233.5%)
-$3.34M(-147.1%)
Jun 2020
-
-$1.38M(-341.4%)
$7.10M(-1.5%)
Mar 2020
-
$570.00K(-72.3%)
$7.21M(+36.5%)
Dec 2019
$5.28M(-182.9%)
$2.06M(-64.9%)
$5.28M(+63.8%)
Sep 2019
-
$5.85M(-560.9%)
$3.22M(-222.7%)
Jun 2019
-
-$1.27M(-6.5%)
-$2.63M(-41.8%)
Mar 2019
-
-$1.36M(-57.0%)
-$4.51M(-33.5%)
Dec 2018
-$6.37M(-48.5%)
-
-
Jun 2018
-
-$3.15M(-13.1%)
-$6.79M(+86.9%)
Mar 2018
-
-$3.63M
-$3.63M
Dec 2017
-$12.37M
-
-

FAQ

  • What is Castle Biosciences, Inc. annual net profit?
  • What is the all time high annual net income for Castle Biosciences, Inc.?
  • What is Castle Biosciences, Inc. annual net income year-on-year change?
  • What is Castle Biosciences, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Castle Biosciences, Inc.?
  • What is Castle Biosciences, Inc. quarterly net income year-on-year change?
  • What is Castle Biosciences, Inc. TTM net profit?
  • What is the all time high TTM net income for Castle Biosciences, Inc.?
  • What is Castle Biosciences, Inc. TTM net income year-on-year change?

What is Castle Biosciences, Inc. annual net profit?

The current annual net income of CSTL is $18.25M

What is the all time high annual net income for Castle Biosciences, Inc.?

Castle Biosciences, Inc. all-time high annual net profit is $18.25M

What is Castle Biosciences, Inc. annual net income year-on-year change?

Over the past year, CSTL annual net profit has changed by +$75.71M (+131.75%)

What is Castle Biosciences, Inc. quarterly net profit?

The current quarterly net income of CSTL is $4.52M

What is the all time high quarterly net income for Castle Biosciences, Inc.?

Castle Biosciences, Inc. all-time high quarterly net profit is $9.59M

What is Castle Biosciences, Inc. quarterly net income year-on-year change?

Over the past year, CSTL quarterly net profit has changed by -$4.40M (-49.29%)

What is Castle Biosciences, Inc. TTM net profit?

The current TTM net income of CSTL is -$9.47M

What is the all time high TTM net income for Castle Biosciences, Inc.?

Castle Biosciences, Inc. all-time high TTM net profit is $18.25M

What is Castle Biosciences, Inc. TTM net income year-on-year change?

Over the past year, CSTL TTM net profit has changed by -$6.37M (-205.45%)
On this page